Inderjit Kaul - 14 Nov 2025 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
Director
Signature
/s/ Frederick Ahlholm, Attorney-in-Fact
Issuer symbol
NERV
Transactions as of
14 Nov 2025
Transactions value $
$0
Form type
4
Filing time
18 Nov 2025, 16:49:27 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kaul Inderjit Director C/O MINERVA NEUROSCIENCES, INC., 1500 DISTRICT AVENUE, BURLINGTON /s/ Frederick Ahlholm, Attorney-in-Fact 18 Nov 2025 0002095703

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Stock Option (right to buy) Award $0 +9.5K $0.00 9.5K 14 Nov 2025 Common Stock 9.5K $4.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest in equal quarterly installments over three years with the first installment vesting on February 14, 2026, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.